Protagonist Therapeutics Stock Analysis
| PTGX Stock | USD 49.56 1.49 2.92% |
Protagonist Therapeutics is fairly valued with Real Value of 49.12 and Hype Value of 49.46. The main objective of Protagonist Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Protagonist Therapeutics is worth, separate from its market price. There are two main types of Protagonist Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Protagonist Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Protagonist Therapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Protagonist Stock trading window is adjusted to America/New York timezone.
Protagonist |
Protagonist Stock Analysis Notes
About 99.0% of the company shares are owned by institutional investors. The book value of Protagonist Therapeutics was at this time reported as 11.06. The company had not issued any dividends in recent years. Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California. Protagonist Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 127 people. To find out more about Protagonist Therapeutics contact Dinesh Patel at 510 474 0170 or learn more at https://www.protagonist-inc.com.Protagonist Therapeutics Investment Alerts
| Protagonist Therapeutics is way too risky over 90 days horizon | |
| Protagonist Therapeutics appears to be risky and price may revert if volatility continues | |
| Over 99.0% of the company shares are owned by institutional investors |
Protagonist Therapeutics Upcoming and Recent Events
Earnings reports are used by Protagonist Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Protagonist Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.22 B.Protagonist Profitablity
The company has Profit Margin (PM) of 0.63 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.74 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.74.Technical Drivers
As of the 26th of March, Protagonist Therapeutics holds the Coefficient Of Variation of 1196.96, risk adjusted performance of 0.0793, and Semi Deviation of 2.4. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Protagonist Therapeutics, as well as the relationship between them.Protagonist Therapeutics Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Protagonist Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Protagonist Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Protagonist Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Protagonist Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Protagonist Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Protagonist Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Protagonist Therapeutics Outstanding Bonds
Protagonist Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Protagonist Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Protagonist bonds can be classified according to their maturity, which is the date when Protagonist Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| PL 1618 15 APR 26 Corp BondUS74368CBC73 | View | |
| US74368CAX20 Corp BondUS74368CAX20 | View | |
| US743674BE29 Corp BondUS743674BE29 | View | |
| US74368CAY03 Corp BondUS74368CAY03 | View | |
| PRXNA 3832 08 FEB 51 Corp BondUS74365PAE88 | View | |
| PL 5366 06 JAN 26 Corp BondUS74368CBQ69 | View | |
| PRXNA 4027 03 AUG 50 Corp BondUS74365PAD06 | View | |
| PRXNA 3257 19 JAN 27 Corp BondUS74365PAG37 | View |
Protagonist Therapeutics Predictive Daily Indicators
Protagonist Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Protagonist Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 34314.94 | |||
| Daily Balance Of Power | (0.74) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 50.4 | |||
| Day Typical Price | 50.12 | |||
| Price Action Indicator | (1.58) | |||
| Period Momentum Indicator | (1.49) | |||
| Relative Strength Index | 79.16 |
Protagonist Therapeutics Forecast Models
Protagonist Therapeutics' time-series forecasting models are one of many Protagonist Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Protagonist Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Protagonist Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Protagonist Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Protagonist shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Protagonist Therapeutics. By using and applying Protagonist Stock analysis, traders can create a robust methodology for identifying Protagonist entry and exit points for their positions.
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California. Protagonist Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 127 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Protagonist Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.